As the clinical trial industry is fully committing to the adoption of technology, MRN is listening and advancing its digital technology platform to fully support the demands of Decentralized Clinical Trials, Virtual Clinical Trials and Hybrid Clinical Trials.

In this webinar, the speaker will discuss implementation considerations along with the studies and patient populations who would most benefit from technological support.

At MRN, patients have and always will be at the heart of our DNA – it’s important to provide them with a protocol design that best supports them, their families and communities. We’ve been using our expertise for the last 15 years to improve recruitment and retention rates and accelerate the drug development process, all while limiting the intrusiveness on patients as much as possible. Now we want to share our expertise with you.

Register for this webinar to hear the experts from MRN share the key considerations around implementing technology and technological elements within clinical trials, their recommendations on the best practices for integrating new systems and technologies, as well as what the future looks like when it comes to technology and decentralized trials.

Keywords:

Speaker

Edward Triebell, Executive Director, Product Development of Digital Health, MRN

Edward Triebell is the Executive Director, Product Development of Digital Health at MRN and is responsible for the launch of new products and services in the pivoting digital health and data centric operating environment of clinical trials.

His career has focused on the forefront of disruptive innovations in the telecommunications, semiconductor, SaaS/PaaS software platforms, mobile/cellular data networks and the healthcare industry for more than 30 years. His career started in designing engineering and then migrated into significant roles in project engineering, program management, global sales, product marketing and strategic business development for enterprises focused on digital technology innovation.

Within the healthcare industry, he has been involved with strategic programs that included the creation of a private satellite-based telemedicine platform for the Mayo Clinic network of hospitals to accomplish remote diagnosis and surgical treatments with high resolution imaging/videos, RFID solutions for patient tracking within Emergency Departments as well as audited tracking of patient biological samples, outsourcing radiological contouring services for cancer treatments using a joint-venture with a leading cancer hospital in China, and pivoting an Internet of Things (IoT) software platform into a leading ePRO (electronic Patient-Reported Outcomes) platform that including integration with advanced biosensors for real world data-based patient health monitoring in clinical trials.

Edward’s educational background includes his Bachelor of Science degree and Master’s degree coursework in Electrical Engineering, additional graduate coursework for his Master’s degree in Business Administration and completion of an Executive Management program at the Aresty Institute of Executive Education at the Wharton School at the University of Pennsylvania.

Message Presenter

Who Should Attend?

From Sponsor Organisations:

Senior VP
Clinical Operations
Clinical Innovation
Data Management
Medical Affairs

From Mid-size CROs:

Site Support
Data Management
Vendor Contracts
Innovation

From Sites:

Site Teams
Project Managers

From Medical Device Suppliers:

What You Will Learn

In this webinar, participants will learn about:

Key considerations around technology implementation within decentralized clinical trials
Best practices for integrating new systems/technology
Future roadmap of technology within clinical studies
Remembering the importance of human interaction with patients

Xtalks Partner

MRN

Our focus is supporting clinical research delivery, by helping patients participate in trials while remaining in their communities, wherever they live around the world. We aim to reduce the inconvenience and disruption of visits to investigator sites as much as feasible, by reducing the number of those visits. When visits need to be undertaken we work to make the process as efficient and convenient as possible. We enhance patient enrolment, recruitment and retention.

As the largest international provider of specialist community clinical trial support, our services set the benchmarks for high-quality and innovative delivery. MRN is at the core of the clinical trial market and everything we do has always been focused on the patient.

Increased patient centricity is changing clinical research – This is, and always will be, a core part of Medical Research Network’s DNA.